Table 1.
Part A: All tumors | |||
---|---|---|---|
Cytoplasmic ERβ expression | Nuclear ERβ expression | ||
no/low | intermediate | maximal | |
no/low | 18 | 19 | 11 |
intermediate | 0 | 16 | 32 |
maximal | 0 | 1 | 38 |
Part B: Tumors with no/low total ERβ expression (n=42) | |||
---|---|---|---|
Cytoplasmic ERβ expression | Nuclear ERβ expression | ||
no/low | intermediate | maximal | |
no/low | 18 | 17 | 7 |
intermediate | 0 | 0 | 0 |
maximal | 0 | 0 | 0 |
Part C: Tumors with intermediate total ERβ expression (n=55) | |||
---|---|---|---|
Cytoplasmic ERβ expression | Nuclear ERβ expression | ||
no/low | intermediate | maximal | |
no/low | 0 | 2 | 4 |
intermediate | 0 | 16 | 32 |
maximal | 0 | 1 | 0 |
Part D: Tumors with maximal total ERβ expression (n=38) | |||
---|---|---|---|
Cytoplasmic ERβ expression | Nuclear ERβ expression | ||
no/low | intermediate | maximal | |
no/low | 0 | 0 | 0 |
intermediate | 0 | 0 | 0 |
maximal | 0 | 0 | 38 |